Diagnostics & Research
The Diagnostics & Research industry has a total of 63 stocks, with a combined market cap of $787.64 billion, total revenue of $155.94 billion and a weighted average PE ratio of 58.97.
Market Cap
787.64B
Revenue
155.94B
Profits
13.36B
PE Ratio
58.97
Profit Margin
8.57%
Dividend Yield
0.19%
63 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 226.90B | -0.31% | 1,036,487 | 42.49B |
| 2 | DHR | Danaher Corporation | 196.74B | 0.36% | 2,507,822 | 22.52B |
| 3 | A | Agilent Technologies, Inc. | 45.27B | -0.05% | 1,365,185 | 6.74B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 44.84B | 0.46% | 297,786 | 3.72B |
| 5 | IQV | IQVIA Holdings Inc. | 42.15B | -1.63% | 432,777 | 15.07B |
| 6 | MTD | Mettler-Toledo International Inc. | 32.45B | -0.51% | 112,030 | 3.79B |
| 7 | ICLR | ICON PLC | 26.02B | -0.35% | 165,615 | 8.23B |
| 8 | WAT | Waters Corporation | 21.14B | -1.26% | 259,866 | 2.91B |
| 9 | LH | Laboratory Corporation of America Holdings | 17.72B | - | 469,368 | 12.30B |
| 10 | ILMN | Illumina, Inc. | 17.65B | -2.96% | 738,263 | 4.49B |
| 11 | DGX | Quest Diagnostics Incorporated | 16.04B | 1.34% | 946,153 | 9.29B |
| 12 | RVTY | Revvity, Inc. | 13.58B | 1.63% | 718,639 | 2.73B |
| 13 | NTRA | Natera, Inc. | 13.11B | -1.88% | 713,391 | 1.21B |
| 14 | MEDP | Medpace Holdings, Inc. | 12.19B | 0.01% | 80,708 | 1.96B |
| 15 | CRL | Charles River Laboratories International, Inc. | 11.37B | -1.40% | 745,511 | 4.11B |
| 16 | QGEN | Qiagen N.V. | 10.12B | -0.65% | 1,034,370 | 1.94B |
| 17 | EXAS | Exact Sciences Corporation | 9.32B | -3.02% | 1,631,801 | 2.53B |
| 18 | RDNT | RadNet, Inc. | 4.24B | -0.23% | 231,400 | 1.66B |
| 19 | SHC | Sotera Health Company | 3.20B | -1.05% | 321,860 | 1.08B |
| 20 | GH | Guardant Health, Inc. | 3.09B | -3.35% | 1,914,622 | 603.73M |
| 21 | OLK | Olink Holding AB (publ) | 2.98B | - | 130,133 | 170.89M |
| 22 | NEOG | Neogen Corporation | 2.93B | 0.97% | 1,917,256 | 929.24M |
| 23 | TWST | Twist Bioscience Corporation | 2.74B | 1.10% | 432,577 | 277.49M |
| 24 | MYGN | Myriad Genetics, Inc. | 2.29B | 2.76% | 410,504 | 774.20M |
| 25 | NEO | NeoGenomics, Inc. | 1.88B | -1.27% | 424,589 | 610.66M |
| 26 | VCYT | Veracyte, Inc. | 1.75B | -2.22% | 415,371 | 375.47M |
| 27 | LAB | Standard BioTools Inc. | 980.61M | 2.80% | 2,538,436 | 126.76M |
| 28 | OPK | OPKO Health, Inc. | 917.24M | 1.54% | 2,397,859 | 799.60M |
| 29 | CDNA | CareDx, Inc | 802.35M | 4.87% | 502,586 | 275.11M |
| 30 | CSTL | Castle Biosciences, Inc. | 669.20M | 0.08% | 168,776 | 250.73M |
| 31 | FLGT | Fulgent Genetics, Inc. | 658.93M | -1.73% | 61,897 | 287.53M |
| 32 | ME | 23andMe Holding Co. | 281.83M | -1.73% | 1,988,208 | 247.99M |
| 33 | SERA | Sera Prognostics, Inc. | 261.41M | -1.43% | 116,130 | 206.00K |
| 34 | BDSX | Biodesix, Inc. | 180.06M | 0.96% | 45,111 | 54.85M |
| 35 | FONR | FONAR Corporation | 97.70M | -2.99% | 28,023 | 102.72M |
| 36 | PRPH | ProPhase Labs, Inc. | 95.49M | -1.57% | 50,744 | 28.72M |
| 37 | TTOO | T2 Biosystems, Inc. | 87.59M | - | 172,757 | 7.18M |
| 38 | BNR | Burning Rock Biotech Limited | 85.28M | 3.23% | 6,235 | 75.80M |
| 39 | ACRS | Aclaris Therapeutics, Inc. | 84.45M | 0.85% | 381,285 | 31.12M |
| 40 | MDXH | MDxHealth SA | 78.04M | 0.70% | 34,860 | 75.33M |
| 41 | STIM | Neuronetics, Inc. | 77.99M | 3.57% | 201,468 | 73.23M |
| 42 | PSNL | Personalis, Inc. | 72.45M | 0.36% | 146,048 | 74.15M |
| 43 | PRE | Prenetics Global Limited | 69.64M | -0.62% | 1,499 | 21.74M |
| 44 | VNRX | VolitionRx Limited | 63.77M | -3.75% | 72,309 | 797.03K |
| 45 | ENZ | Enzo Biochem, Inc. | 56.35M | -1.80% | 28,805 | 12.81M |
| 46 | NOTV | Inotiv, Inc. | 50.29M | -9.81% | 719,378 | 552.74M |
| 47 | OCX | OncoCyte Corporation | 39.49M | -3.93% | 30,832 | 1.38M |
| 48 | AWH | Aspira Women's Health Inc. | 33.05M | 0.76% | 47,739 | 8.99M |
| 49 | XGN | Exagen Inc. | 32.75M | -0.53% | 26,605 | 55.73M |
| 50 | BIAF | bioAffinity Technologies, Inc. | 26.14M | -7.76% | 129,488 | 4.94M |
| 51 | DMTK | DermTech, Inc. | 17.42M | -12.54% | 568,671 | 15.66M |
| 52 | PMD | Psychemedics Corporation | 14.98M | 0.78% | 2,641 | 21.60M |
| 53 | MYNZ | Mainz Biomed B.V. | 14.88M | 5.25% | 83,450 | 895.48K |
| 54 | STRR | Star Equity Holdings, Inc. | 14.42M | -1.15% | 19,910 | 45.79M |
| 55 | CHEK | Check-Cap Ltd. | 13.05M | 0.23% | 13,393 | - |
| 56 | TRIB | Trinity Biotech plc | 12.19M | - | 3,059 | 56.83M |
| 57 | GENE | Genetic Technologies Limited | 10.60M | 0.88% | 23,974 | 5.78M |
| 58 | CNTG | Centogene N.V. | 10.31M | -2.63% | 494,924 | 53.93M |
| 59 | PRPO | Precipio, Inc. | 9.55M | 4.14% | 13,965 | 15.81M |
| 60 | XWEL | XWELL, Inc. | 7.53M | -2.79% | 8,409 | 31.77M |
| 61 | NDRA | ENDRA Life Sciences Inc. | 3.31M | 8.94% | 454,638 | - |
| 62 | APDN | Applied DNA Sciences, Inc. | 2.47M | -10.04% | 63,072 | 5.52M |
| 63 | ISPC | iSpecimen Inc. | 2.40M | -4.06% | 406,378 | 9.27M |